Jade Biosciences (JBIO) Change in Acquisitions & Divestments (2022 - 2026)

Jade Biosciences (JBIO) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $65.4 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 409.17% year-over-year to $65.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.4 million (up 72.99% YoY) and the FY2025 annual result came in at $14.4 million, down 80.96% from the prior year.
• Change in Acquisitions & Divestments improved to $65.4 million in Q1 2026, from $12.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $65.4 million in Q1 2026 to a low of $12.5 million in Q1 2022.
• A 5-year average of $31.8 million and a median of $30.6 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments sank 60.81% — and 2026, when it soared 409.17%.
• Tracing JBIO's Change in Acquisitions & Divestments over 5 years: stood at $64.8 million in 2022, then slumped by 48.26% to $33.5 million in 2023, then tumbled by 60.81% to $13.1 million in 2024, then declined by 2.13% to $12.8 million in 2025, then soared by 409.17% to $65.4 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $65.4 million (Q1 2026), $12.8 million (Q1 2025), and $13.1 million (Q4 2024), per Business Quant data.